Merck & Co

Astrazeneca And Merck Get An Fda Priority Review For Lynparza In Prostate Cancer

AstraZeneca (NYSE: AZN) and Merck (NYSE: MRK) continue their quest to gain additional approvals for their blockbuster cancer drug Lynparza. The duo submitted a new application to the Food and Drug Administration for the drug as a treatment for...
Related topics: Astrazeneca, Food And Drug Administration, Prostate Cancer, Cancer, Oncology

Read More →

Merck's Keytruda Could Face Direct Competition From New Chinese Drug

Chinese drug developer BeiGene (NASDAQ: BGNE) announced on Monday strong clinical results for its cancer immunotherapy, tislelizumab. A Phase 3 trial tested the drug alongside two other chemotherapy treatments in patients with non-small cell lung...
Related topics: Nasdaq, Clinical Trials, Cancer, Lung Cancer, Oncology, Chemotherapy

Read More →

Seattle Genetics Up More Than 40% In The Past Year: Here's Why

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Roche Holding AG (RHHBY): Free...

Read More →

Is Merck & Co. (mrk) A Profitable Pick For Value Investors?

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report To read this article on Zacks.com...

Read More →

Pharma Stock Roundup: Lly Dermira Buyout Offer, Pipeline & Regulatory Updates

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Johnson & Johnson (JNJ): Free...

Read More →

Will J&j (jnj) Roll Out Pharma Q4 Earnings With A Beat?

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Johnson & Johnson (JNJ): Free Stock Analysis Report Merck & Co., Inc. (MRK): Free...

Read More →

Bristol-myers' Opdivo-yervoy Sbla For Nsclc Accepted By Fda

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Bristol-Myers Squibb Company...
Related topics: Bristol-Myers Squibb

Read More →

Merck (mrk) Gains As Market Dips: What You Should Know

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report To read this article on Zacks.com...

Read More →

Astrazeneca To End Phase Iii Study On Fish Oil Heart Drug

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report AstraZeneca PLC (AZN): Free Stock...
Related topics: Astrazeneca

Read More →

Nektar Up 25% As Bristol-myers Expands Bempeg Collaboration

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol-Myers Squibb Company (BMY): Free Stock Analysis Report Merck & Co., Inc....
Related topics: Bristol-Myers Squibb

Read More →

Merck's Keytruda Gets Fda Nod For High-risk Bladder Cancer

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Pfizer Inc. (PFE): Free Stock...
Related topics: Food And Drug Administration, Bladder Cancer, Cancer, Oncology, Medical Research, Pfizer

Read More →

Blueprint Medicines Posts Data From Nsclc Study On Pralsetinib

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Roche Holding AG (RHHBY): Free...

Read More →

3 Pharma & Biotech Pipeline Areas To Keep An Eye On In 2020

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Sanofi (SNY): Free Stock Analysis...
Related topics: Sanofi

Read More →

Merck's Keytruda Misses An Important Lung Cancer Goal

Merck's cancer immunotherapy finally hit a stumbling block in a pivotal study with lung cancer patients that caused the stock to slip 1.5% on Tuesday morning. It's more than a little surprising because Keytruda has been taking huge steps toward...
Related topics: Lung Cancer, Cancer, Oncology, Medical Research

Read More →

Merck (mrk) Outpaces Stock Market Gains: What You Should Know

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report To read this article on Zacks.com...

Read More →

Leap Therapeutics Surges On License Agreement With Biegene

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Bristol-Myers Squibb Company...
Related topics: Bristol-Myers Squibb

Read More →

Incyte's (incy) Itacitinib Fails In Late-stage Gvhd Study

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report Novartis AG (NVS): Free Stock...
Related topics: Novartis

Read More →

Novo Nordisk's Shares Up In A Year On Pipeline Progress

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novo Nordisk A/S (NVO): Free Stock Analysis Report Merck & Co., Inc. (MRK): Free...

Read More →

Merck (mrk) Stock Sinks As Market Gains: What You Should Know

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Merck & Co., Inc. (MRK): Free Stock Analysis Report To read this article on Zacks.com...

Read More →

The Zacks Analyst Blog Highlights: Abbvie, Abbott Labs, Allergan, Johnson & Johnson And Merck

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AbbVie Inc. (ABBV): Free Stock Analysis Report Abbott Laboratories (ABT): Free Stock...
Related topics: Abbott Laboratories (ABT)

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.